Your browser doesn't support javascript.
loading
Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients' Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers.
Kafatos, George; Dube, Sabada; Burdon, Peter; Demonty, Gaston; Flinois, Alain; Leclerc, Marjorie; Lowe, Kimberly; Feudjo-Tepie, Maurille; Segaert, Siegfried.
Afiliação
  • Kafatos G; Center for Observational Research, Amgen Ltd, Uxbridge, United Kingdom. Electronic address: gkafatos@amgen.com.
  • Dube S; Center for Observational Research, Amgen Ltd, Uxbridge, United Kingdom.
  • Burdon P; EU Medical Affairs, Amgen (Europe) GmbH, Rotkreuz, Switzerland.
  • Demonty G; Medical Development, Amgen, Brussels, Belgium.
  • Flinois A; RWE/Epi Studies, Kantar Health, Paris, France.
  • Leclerc M; RWE/Epi Studies, Kantar Health, Paris, France.
  • Lowe K; Center for Observational Research, Amgen Inc, Thousand Oaks, CA.
  • Feudjo-Tepie M; Center for Observational Research, Amgen Ltd, Uxbridge, United Kingdom.
  • Segaert S; Dermatologist, Tremelo, Belgium.
Clin Colorectal Cancer ; 19(2): 100-108.e9, 2020 06.
Article em En | MEDLINE | ID: mdl-32113902
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Institutos de Câncer / Toxidermias / Inibidores de Proteínas Quinases / Fármacos Dermatológicos / Adesão à Medicação Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Institutos de Câncer / Toxidermias / Inibidores de Proteínas Quinases / Fármacos Dermatológicos / Adesão à Medicação Idioma: En Ano de publicação: 2020 Tipo de documento: Article